BackPanbela Therapeutics Overview

Panbela Therapeutics Other Liabilities

Track Panbela Therapeutics's other liabilities ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Panbela Therapeutics Other Liabilities History

Loading

Panbela Therapeutics vs. peers: Other Liabilities Comparison

Loading

Panbela Therapeutics Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Panbela Therapeutics (PBLA) FAQ

Panbela Therapeutics (PBLA) currently reports a other liabilities of $0 as of September 2024. In the prior-year period, the figure was $0. Use the charts on this page to explore Panbela Therapeutics's other liabilities history and peer comparisons.

Panbela Therapeutics's other liabilities changed from $0 to $0 (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Panbela Therapeutics reported $0 in other liabilities as of September 2024. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other liabilities of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Panbela Therapeutics, and consider following PBLA for alerts when major investors trade the stock.

Panbela Therapeutics is classified in the Technology sector. On other liabilities, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing PBLA with unrelated industries.